bg.png

Demo Day 2020

8.png
3.png
4.png
1.png
6.png
5.png
2.png
9.png

Hillary Harel

CEO

Innovative decision support tools for health service industry increasing quality of care and saving valuable resources.

 

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Dan Berachowitz

CTO

Prof. Joesf Elidan

CMO

Highlights

Top clinical and AI/ML Experts

 

Multiple signed paid pilots and growing pipeline of clients and distribution partners

 

Patent claims have been registered

 

Awarded and Granted by four government entities including the Bilateral Bird Grant

Winner of Department for International Trade (DIT’s) first-ever "2020 European Women in Tech" 

Named Top AI startup company in "Healthcare Innovation Landscape 2020" Data Roots Labs report

1st Place Winner of MTL Tech Awards 2020 by Printemps numérique and Deloitte OVHcloud

Company Overview

 

Amir Elhasid

VP BD

Low medication adherence, a major cause of poor outcomes and increased costs, is hard to recognize and manage. TimeStamp’s pioneering approach enables the incorporation of IoT into medication providing adherence data into everyday healthcare systems. 

 

Read more


Biobeat develops unique wearable devices for remote. continuous, wireless, accurate, medical-grade monitoring of 15 vital signs including continuous blood pressure (only company worldwide to hold FDA for continuous BP), oxygen saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body temperature, steps, and sweat

The company is developing AI based algorithms to analyze the massive amount of data generated to develop new Biomarkers & Predictive Analytics.





Prof. David Price

CMO

Gad Riesenfeld

CEO

Highlights

Completed the development of first engineering model and app

 

3 Patents submitted

 

Collaboration with a leading pharma  company to develop customized solution

Company Overview

Ian Solomon

CTO

 

Danny Lieberman 

CEO

Read more


Biobeat develops unique wearable devices for remote. continuous, wireless, accurate, medical-grade monitoring of 15 vital signs including continuous blood pressure (only company worldwide to hold FDA for continuous BP), oxygen saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body temperature, steps, and sweat

The company is developing AI based algorithms to analyze the massive amount of data generated to develop new Biomarkers & Predictive Analytics.





Automated patient data collection and monitoring for increasing patient adherence and clinical research efficiency.

Dr. Dan Peres 

CPO

Eugene Kalosha

CTO

Highlights

35 clinical trials on the platform

20 customers including Philips, Theranica Therapeutics and Weizmann Institute

9M patient/device signals

3 FDA approvals

Cash-flow positive

Company Overview

 

Dr. Ulrich Mühlner

Co-Founder & CEO

docdok.health is the "Netflix of Healthcare" utilizing the power of patient generated health data to ​provide tailored medical grade application and digital therapeutics (DTx).

 

Read more...


The ultrasound market is rapidly growing, with ultrasound being the only imaging modality (vs. MR/CT/X-Ray) that continues to expand into new clinical settings including ER, ICU, internal medicine, EMS, special forces unit and GPs. Additional key market drivers include ultrasound devices’ portability, decreasing prices and growing improvements of image quality. Yet, capturing and evaluating ultrasound images is still mostly done visually. Such a process is error prone, time consuming and dependent on the user’s experience.

Our FDA/CE approved solutions automate this process, therefore making the use and analysis of ultrasound images smarter and accessible to all.





Yves Nordmann, M.D.

Co-Founder & CMO

Eitan Arat

CTO

Highlights

Internationally multi-awarded digital health company, first European startup selected for ARC partnership

Clinical work co-developed with two of the Top 10 Hospitals of the World 2020

Multiple top-notch clients and partners like Novartis, AstraZeneca, NovoNordisk, IBM and T-Systems

Active in 5 countries (CH, D, AT, IL and Q)

Company Overview

 

Arik Ben Ishay

CEO

Biobeat has developed an AI-based end-to-end solution for remote patient monitoring. The core of the technology lies in Biobeat’s proprietary sensor, which is able to monitor 15 vital signs wirelessly, continuously and non-invasively.

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Johanan May

CTO

Israel Sarussi

VP R&D

Highlights

$5M in sales across the US and Europe.

Implemented in 13 Hospitals in under 4 weeks for COVID-19 monitoring

Multiple signed MSAs with the world’s biggest pharma companies and CROs

Several paid pilots and POCs lined up in the US throughout the next year.

Company Overview

 

Guy Vinograd

CEO

Bio-T has developed a cloud software that enables medical device manufacturers to seamlessly convert their medical devices to IoT creating a data collection system that manages their device and provides remote care.

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Boaz Vaizler

COO

Daniel Adler

CBO

Highlights

Completed MVP and launched with initial clients, including $Bn mkt cap companies.

Used by thousands of patients in the US market

Closely partnered with Amazon AWS

Growing pipeline with multiple Top 10 lifescience companies

Company Overview

Aviv Lotan

CEO

Developing the 1st respiratory Holter, a small patch, accurately, continuously and passively monitors respiratory patients at all ages.

Read more...


Currently there is no effective way to monitor respiratory outpatients.

Our system measures breathing patterns and volumetric changes of the lung using only a small, unobtrusive passive patch, adhered to the body, that can be used with infants to elderly people.

Remote monitoring of respiratory conditions can improve health outcomes and reduce emergency department visits, hospitalizations, length of hospital stays, and readmissions

Unlike existing devices, our remote monitoring patch can accurately detect mild, asymptomatic irregularities in breathing patterns and timely detect a major respiratory episode allowing for medical intervention and prevent ER visits and hospitalization.





Dr. Zvi Reznic

CTO

Dr. Ari Derowe

CMO

Highlights

Successful clinical POC

Patent granted in the US

Growing interest in clinical collaboration

$1M approved funds from the Israeli Innovation Authority (to be matched)

Company Overview

 
 

Hila Goldman-Aslan

CEO

DiA is the leading provider of AI-powered ultrasound analysis solutions. DiA transforms the way clinicians capture and analyze ultrasound  images.

Our vision is to leverage AI to make the use and analysis of ultrasound images smarter and accessible to all.

Read more...


The ultrasound market is rapidly growing, with ultrasound being the only imaging modality (vs. MR/CT/X-Ray) that continues to expand into new clinical settings including ER, ICU, internal medicine, EMS, special forces unit and GPs. Additional key market drivers include ultrasound devices’ portability, decreasing prices and growing improvements of image quality. Yet, capturing and evaluating ultrasound images is still mostly done visually. Such a process is error prone, time consuming and dependent on the user’s experience.

Our FDA/CE approved solutions automate this process, therefore making the use and analysis of ultrasound images smarter and accessible to all.





Michal Yaacobi

CTO

Highlights

7 FDA and CE approved solutions

8 Channle Partners including GE Healthcare, IBM Watson Health, and Konica Minolta

Serving thousands of end-users in more than 20 countries

Company Overview

 
All rights reserved to ii2020